Michal Pasternak

Michal is passionate about translating scientific discoveries into products that improve people’s lives. He has 12 years of research experience in molecular biology, developmental biology and infectious diseases. He manages Denteric’s mRNA vaccine and Alzheimer’s disease research programs.

​Prior to joining Denteric, Michal was a postdoctoral scientist at WEHI. In addition to this role, he completed an internship at the WEHI’s Business Development Office, the Bridge Program and the Innovation Fellowship with an Israeli VC fund aMoon. Michal is a recipient of fellowships from Boehringer-Ingelheim Fonds, EMBO and Wellcome Trust, and several leadership awards for his work in the diversity and inclusion space.

​Michal holds a PhD from the University of Cambridge and is currently pursuing an MBA at the Melbourne Business School.